Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Flow diverter vs. stent-assisted coiling for unruptured wide-neck brain aneurysms

Official title: Traditional Approach Versus Flow Diverter for Unruptured Intracranial Wide-neck Bifurcation Aneurysms: a Prospective International Multicenter Randomized Controlled Study (FD-BWA Study)

Run by Nanfang Hospital, Southern Medical University · NCT07707076 · Data updated 2026-11-12

This trial tests whether a flow diverter (Pipeline) is safer or more effective than the traditional stent-assisted coiling for unruptured wide-neck bifurcation brain aneurysms.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment266 (estimated)
SponsorNanfang Hospital, Southern Medical University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedFebruary 10, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2030
Registry record updatedJuly 16, 2026
Trial IDNCT07707076 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 with unruptured wide-neck bifurcation intracranial aneurysms suitable for either treatment option.

Probably not a fit

Patients with multiple aneurysms requiring different treatment or conditions increasing surgical risk may derive less benefit or be excluded from favorable outcomes.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with unruptured wide-neck bifurcation intracranial aneurysms are randomly assigned to receive either a flow diverter or stent-assisted coiling. The study compares complications, stroke or death within one year, and long-term imaging results at 1, 2, and 5 years to assess safety and durability. Outcomes include procedure-related events, medical problems during follow-up, and imaging-based cure or stability over time. The trial is conducted at several hospitals in China with international collaboration. Eligibility targets adults 18–75 without recent ruptures or severe comorbidity.

Why it matters

Potential benefit: If successful, the trial could clarify which approach offers better safety and sustained effectiveness for this aneurysm type.

How similar studies have gone: Previous experience with flow diverters and stent-assisted coiling supports both approaches; comparative data in this exact aneurysm subtype is being explored in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-75 years;
2. Diagnosis of unruptured intracranial, bifurcation, saccular, wide-neck aneurysm by DSA/CTA/MRA;
3. Patients who can understand the purpose of the trial, voluntarily participate and sign the informed consent form.

Exclusion Criteria:

1. Patients with two or more multiple aneurysms that all require treatment within 1 year;
2. Concomitant cerebrovascular diseases such as arteriovenous malformation, moyamoya disease;
3. Ruptured aneurysms and narrow-neck aneurysms;
4. Patients who have had a stroke (cerebral hemorrhage, cerebral infarction) within the past 1 month;
5. Extremely poor clinical condition, modified Rankin Score ≥3;
6. Patients already scheduled for surgery/interventional procedure within 3 months;
7. Patients deemed unsuitable for interventional treatment by the investigator (e.g., no suitable vascular access, excessively tortuous vessels, difficulty delivering stent);
8. Patients unsuitable for anesthesia or endovascular surgery, such as major diseases of heart, lung, liver, spleen, kidney, brain tumors, severe active infections, disseminated intravascular coagulation, severe mental illness;
9. Patients unable to receive antiplatelet or anticoagulant therapy;
10. Patients who have had or may have severe reactions to contrast media precluding pre-treatment medication;
11. Patients with a definite history of allergy to cobalt-chromium, nickel-titanium alloy materials;
12. Participation in other drug or medical device clinical trials before enrollment without reaching the primary endpoint timeframe;
13. Pregnant or breastfeeding women;
14. Patient's life expectancy less than 12 months;
15. Investigator judges that the patient has poor compliance and cannot complete the study as required.

Where it's running

  • Nanfang Hospital, Southern Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.